International Investment in the U.S. Life Sciences Market

Monday, January 12, 2015
Breakfast and networking: 8:30 a.m. – 9:00 a.m.
Program: 9:00 a.m. – 10:00 a.m.

REGISTER

Foreign investment in U.S. companies is on the rise. Stephen Thau will lead a panel discussion on foreign investment in U.S. life sciences companies, including:

• The types of life sciences companies they are attracted to and why
• The various types of investors and the differing value proposition associated with each
• Differences (and similarities) in deal structuring and execution

Speakers:

• Stephen Thau
  Partner, Morrison & Foerster LLP
• Frank Yu
  Founder and CEO, Themes Investment Partners and Ally Bridge Group
• Dr. Guo-Liang Yu
  Executive Chairman, Crown Biosicence Inc.

Connections and Collaborations: High Tech + Life Sciences

Tuesday, January 13, 2015
Breakfast and networking: 8:30 a.m. – 9:00 a.m.
Program: 9:00 a.m. – 10:00 a.m.

REGISTER

High technology and life sciences are coming together to create fundamental change in what healthcare means and what it looks like. The discussion, led by Van Ellis, will cover the convergence of high tech and life sciences, including:

• Intellectual property and the differing views on patent protection
• The collection and sharing of personal data and other privacy matters
• Licensing and collaborations to facilitate the integration of high tech and big pharma

Speakers:

• Van Ellis
  Partner, Morrison & Foerster LLP
• Christine Lyon
  Partner, Morrison & Foerster LLP
• Walter Wu
  Of Counsel, Morrison & Foerster LLP

Structured Debt + Equity Investments for Life Sciences Companies

Wednesday, January 14, 2015
Breakfast and networking: 8:30 a.m. – 9:00 a.m.
Program: 9:00 a.m. – 10:00 a.m.

REGISTER

The panel discussion, led by Bill Veatch, will cover the latest debt structures for investing in healthcare companies, including:

• The types of healthcare companies that lenders are attracted to and why
• How the loans are structured from a collateral perspective
• Secured debt versus true sales of royalties
• Bankruptcy issues in structuring royalty finance transactions, including Section 552 of the Bankruptcy Code

Speakers:

• Bill Veatch
  Partner, Morrison & Foerster LLP
• Luke Duster
  Managing Director, CRG LP
• Larry Engel
  Partner, Morrison & Foerster LLP
• Catherine Young Hagerty
  Of Counsel, Morrison & Foerster LLP